Unique Ingredient Identifier PDC6A3C0OX is listed as a ingredient substance
| RN | 56-81-5 |
| EC | 200-289-5 |
| NCIT | C29077 |
| RXCUI | 4910 |
| PUBCHEM | 753 |
| INN ID | 444 |
| MF | C3H8O3 |
| INCHI KEY | PEDCQBHIVMGVHV-UHFFFAOYSA-N |
| SMILES | OCC(O)CO |
UNII PDC6A3C0OX GLYCERIN is commonly included in medications in the following forms.
| Route | Dosage Form | Potency |
|---|---|---|
| AURICULAR (OTIC) | SOLUTION | 63.64 % |
| AURICULAR (OTIC) | SOLUTION, DROPS | 2.5 % |
| AURICULAR (OTIC) | SUSPENSION | 0.05 % |
| BUCCAL | GUM, CHEWING | 28.8 MG |
| BUCCAL | PATCH, CONTROLLED RELEASE | 66 MG |
| DENTAL | PASTE | NA |
| DENTAL | TABLET | 0.53 MG |
| IM - IV | INJECTION | 15 % |
| IM - IV - SC | INJECTION | 15.36 % |
| IM - IV - SC | POWDER, FOR INJECTION SOLUTION | 1.2 % |
| IM - SC | INJECTION | 1.6 % |
| INHALATION | SOLUTION | 7.3 % |
| INTRADERMAL | INJECTION | 1.6 % |
| INTRAMUSCULAR | INJECTABLE | 1.78 %W/V |
| INTRAMUSCULAR | INJECTION | 17.81 mg/1mL |
| INTRAMUSCULAR | INJECTION | 15 % |
| INTRAMUSCULAR | INJECTION, SOLUTION | 15 % |
| INTRAVENOUS | EMULSION, INJECTION | 2.5 % |
| INTRAVENOUS | INJECTABLE | 2.25 % |
| INTRAVENOUS | INJECTION | 15 % |
| INTRAVENOUS | INJECTION, EMULSION | 2.5 % |
| INTRAVENOUS | INJECTION, SOLUTION | 15 % |
| INTRAVENOUS | SOLUTION, INJECTION | 18.82 MG/1ML |
| IONTOPHORESIS | PATCH, CONTROLLED RELEASE | 168.1 MG |
| IV - SC | INJECTION | 1.2 % |
| IV - SC | INJECTION, SOLUTION | 3.3 MG/1ML |
| IV(INFUSION) | EMULSION | NA |
| IV(INFUSION) | EMULSION, INJECTION | 22.5 % |
| IV(INFUSION) | POWDER, FOR INJECTION SOLUTION, LYOPHILIZED | 22.5 % |
| NASAL | GEL | NA |
| NASAL | SOLUTION | 2.5 % |
| NASAL | SPRAY | 2.3 % |
| NASAL | SPRAY, METERED | 3219.5 MCG/SPRAY |
| OPHTHALMIC | DROPS | 2.25 % |
| OPHTHALMIC | EMULSION | 2.2 % |
| OPHTHALMIC | GEL | 0.88 % |
| OPHTHALMIC | SOLUTION | 20 MG/1ML |
| OPHTHALMIC | SOLUTION | 3 % |
| OPHTHALMIC | SUSPENSION | 2.5 % |
| OPHTHALMIC | SUSPENSION, DROPS | 2.5 % |
| ORAL | BAR, CHEWABLE | NA |
| ORAL | CAPSULE | 249.1 MG |
| ORAL | CAPSULE (IMMED./COMP. RELEASE), COATED, SOFT GELAT | 41 MG |
| ORAL | CAPSULE (IMMED./COMP. RELEASE), SOFT GELATIN | 223.52 MG |
| ORAL | CAPSULE (IMMED./COMP. RELEASE), SOFT GELATIN, PERL | 43.85 MG |
| ORAL | CAPSULE, COATED, SOFT GELATIN | 91.5 MG |
| ORAL | CAPSULE, DELAYED ACTION | NA |
| ORAL | CAPSULE, GELATIN COATED | 3.37 MG |
| ORAL | CAPSULE, HARD GELATIN | NA |
| ORAL | CAPSULE, SOFT GELATIN | 204.2 MG |
| ORAL | CAPSULE, SOFT GELATIN LIQUID-FILLED | 40 MG |
| ORAL | CAPSULE, SUSTAINED ACTION | 132.32 MG |
| ORAL | CONCENTRATE | 750 MG/1ML |
| ORAL | DROPS | 100 MG/1ML |
| ORAL | INJECTION | 25 MG/1ML |
| ORAL | LIQUID | 885.5 MG/1ML |
| ORAL | LIQUID | 637.5 mg/10mL |
| ORAL | ORAL SOLUTION DOSAGE FORM | 500 mg/5mL |
| ORAL | SOFT CAPSULE DOSAGE FORM | 59.14 mg |
| ORAL | SOLUTION | 3077 mg/5mL |
| ORAL | SOLUTION | 1500 mg/15 mL |
| ORAL | SOLUTION | 1249 mg/5 mL |
| ORAL | SOLUTION | 18.64 %W/W |
| ORAL | SOLUTION, CONCENTRATE | 200 MG/1ML |
| ORAL | SOLUTION, ELIXIR | 3108 MG/15ML |
| ORAL | SOLUTION, LIQUID | 222 MG/1ML |
| ORAL | SOLUTION, LIQUID, CONCENTRATE, ORAL | 1010.81 MG/1ML |
| ORAL | SOLUTION, SYRUP | 1235 MG/5ML |
| ORAL | SUSPENSION | 2870.55 MG/5ML |
| ORAL | SUSPENSION | 62.5 mg/1.25mL |
| ORAL | SUSPENSION, DROPS | 250 MG/2.5ML |
| ORAL | SUSPENSION, EXTENDED RELEASE | 100 MG/1ML |
| ORAL | SUSPENSION, LIQUID | 500 MG/1ML |
| ORAL | SUSPENSION, SYRUP, SUSTAINED ACTION | 2 % |
| ORAL | SYRUP | 65 % |
| ORAL | TABLET | 16 MG |
| ORAL | TABLET (IMMED./COMP. RELEASE), FILM COATED | 1.4 MG |
| ORAL | TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE | 1 MG |
| ORAL | TABLET, COATED | 0.58 MG |
| ORAL | TABLET, EXTENDED RELEASE | 3.64 MG |
| ORAL | TABLET, FILM COATED | 1.55 MG |
| ORAL | TABLET, SUSTAINED ACTION | 3.45 MG |
| PERFUSION, BILIARY | LIQUID | 2.5 % |
| RECTAL | SUPPOSITORY | 128 MG |
| SUBCUTANEOUS | INJECTABLE | 2 % |
| SUBCUTANEOUS | INJECTION | 32.5 % |
| SUBCUTANEOUS | INJECTION, SOLUTION | 15 % |
| SUBCUTANEOUS | SOLUTION, INJECTION | 1.9 % |
| SUBCUTANEOUS | SUSPENSION | 1.6 % |
| SUBCUTANEOUS | SUSPENSION, INJECTION | 1.6 % |
| TOPICAL | AEROSOL | 3 %W/W |
| TOPICAL | CREAM | 20 %W/W |
| TOPICAL | CREAM | 20 %W/W |
| TOPICAL | CREAM, AUGMENTED | 4 %W/W |
| TOPICAL | CREAM, EMULSION, SUSTAINED RELEASE | 3 %W/W |
| TOPICAL | DROPS | NA |
| TOPICAL | EMULSION, AEROSOL FOAM | 2.11 %W/W |
| TOPICAL | EMULSION, CREAM | 20 %W/W |
| TOPICAL | EMULSION, CREAM | 6 %W/W |
| TOPICAL | FILM, CONTROLLED RELEASE | 2520 MG |
| TOPICAL | GEL | 20 %W/W |
| TOPICAL | LIQUID | 7.2 %W/W |
| TOPICAL | LOTION | 11.2 %W/W |
| TOPICAL | OINTMENT | NA |
| TOPICAL | OPHTHALMIC SUSPENSION DOSAGE FORM | 0.6 %W/V |
| TOPICAL | PATCH | 2870 MG |
| TOPICAL | PATCH, CONTROLLED RELEASE | 168.1 MG |
| TOPICAL | SOLUTION | 20 MG/1ML |
| TOPICAL | SOLUTION | 11.5 %W/W |
| TOPICAL | SPONGE | NA |
| TOPICAL | SUPPOSITORY, INSERT | NA |
| TOPICAL | SUSPENSION | 5 %W/W |
| TRANSDERMAL | FILM, CONTROLLED RELEASE | 306.2 MG |
| TRANSDERMAL | GEL | 5 %W/W |
| VAGINAL | CREAM, EMULSION, SUSTAINED RELEASE | 17 %W/W |
| VAGINAL | EMULSION, CREAM | 5 %W/W |
| VAGINAL | GEL | 14.51 % |
| VAGINAL | INSERT | 22 MG |
| VAGINAL | SUPPOSITORY | 227.9 MG |